Botanical Support Products Learn More

Cansema® is a topical ointment that, when applied to cancerous lesions of the dermis and epidermis, necroses the aberrant tissue (i.e. kills the cancer cells), creates an "eschar" (what would appear to the layman as a pus formation) -- after which the body itself expels the "scab," leaving a pit ("decavitated area").

Cansema® is a miraculous product with a miraculous history.
It is the latest and most advanced in a category of cancer-killing ointments historically known as "escharotics" (Gk. "escharotikos"). Most of those which have been discovered, manufactured, utilized and/or patented in the U.S. over the last 100 years have been composed of the caustic compound, zinc chloride, plus one or more medicinal herbs, of which most have anti-microbial properties. Learn More

Including osteosarcoma, Ewing's sarcoma, chondrasarcoma, c-bone and secondary bone cancer.

Bone cancer describe a variety of different cancers, which either originate in the bone ("primary") or develop as a result of metastasis from elsewhere in the body ("secondary"). Learn More

Including cancers / malignant tumors of the brain & central nervous system, including astrocytes, brain stem glioma, ependymoma, germinoma, meningioma, oligodendroglioma, pineocytoma, and schwannoma.

Brain cancer describes a variety of different cancers of the brain and central nervous system. These can either originate in the brain or central nervous system ("primary") or develop as a result of metastasis from elsewhere in the body ("secondary"). Along with lung cancers, brain cancers lead among secondary growths caused by metastasis. Learn More

Excludes the following tumor types, which may occur in the breast but are not morphologically breast cancer: angiosarcoma, cystosarcoma, phyllodes, and primary lymphoma.

Breast cancer is the most common type of cancer among women, next to skin cancer. It can either originate in breast tissue ("primary") or develop as a result of metastasis from elsewhere in the body ("secondary"). Learn More

Including cancers / polyps ofthe rectum, sigmoid, and colon.

Colorectal cancers are among the deadliest (second leading cause of cancer death in the U.S. alone), yet least-well-known among cancer types. They are quite common -- about 4% of all women will develop colorectal cancer sometime within their lifetime; 5% for men. Unchecked, undiagnosed colon polyps are a common condition leading up to the disease. It takes anywhere from 5 to 15 years for a polyp to reach malignancy. Conditions that aggrevate include inadequate exercise, smoking, alcohol consumption, and genetic predisposition. Learn More

Including cholangiocarcinoma and cystadenocarcinoma; hepatoblastoma; mesenchymal and renal carcinomas.

Cancers of the liver and kidney are relatively rare compared to others mentioned herein. Found more often in men than women, risk of liver cancer greatly increases when a subject has had hepatitis B or C, or cirrhosis. Kidney cancer is a little more common, and later stage symptoms are quite specific: blood in the urine; a lump or mass in the kidney areas. A qualified urologist provides the best source of diagnosis. Learn More

Including all classes and subclasses of these malignant blood-related cancers

Leukemia and lymphoma both belong to a class of cancers dealing with the blood-forming and immune systems: bone marrow and lymph nodes. Others in this class include Hodgkin's disease and myeloma.

Learn More

Lung cancer is a leading cause of death in the West, its greatest anamoly being that it is primarily self-inflicted: over 80% of lung cancers are caused by smoking; next is residential radon, a by-product of naturally-occurring breakdown of radium, which comes from decaying uranium. One in fifteen homes has been calculated to have ambient radon levels exceeding safe levels. Lastly, comes work-related carcinogens - again, self-infliction. Learn More